Saur D - Search Results

1

Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting.

Cheung PF, Neff F, Neander C, Bazarna A, Savvatakis K, Liffers ST, Althoff K, Lee CL, Moding EJ, Kirsch DG, Saur D, Bazhin AV, Trajkovic-Arsic M, Heikenwalder MF, Siveke JT. Cheung PF, et al. Among authors: saur d. Cancer Res. 2018 Sep 1;78(17):4997-5010. doi: 10.1158/0008-5472.CAN-18-0052. Epub 2018 May 29. Cancer Res. 2018. PMID: 29844119

2

IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression.

Schneider G, Saur D, Siveke JT, Fritsch R, Greten FR, Schmid RM. Schneider G, et al. Among authors: saur d. EMBO J. 2006 Aug 23;25(16):3801-12. doi: 10.1038/sj.emboj.7601259. Epub 2006 Aug 10. EMBO J. 2006. PMID: 16902410 Free PMC article.

3

Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.

Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G. Reichert M, et al. Among authors: saur d. Cancer Res. 2007 May 1;67(9):4149-56. doi: 10.1158/0008-5472.CAN-06-4484. Cancer Res. 2007. PMID: 17483325

4

HMGA1 controls transcription of insulin receptor to regulate cyclin D1 translation in pancreatic cancer cells.

Kolb S, Fritsch R, Saur D, Reichert M, Schmid RM, Schneider G. Kolb S, et al. Among authors: saur d. Cancer Res. 2007 May 15;67(10):4679-86. doi: 10.1158/0008-5472.CAN-06-3308. Cancer Res. 2007. PMID: 17510394

5

Molecular biology of pancreatic cancer--new aspects and targets.

Schneider G, Hamacher R, Eser S, Friess H, Schmid RM, Saur D. Schneider G, et al. Among authors: saur d. Anticancer Res. 2008 May-Jun;28(3A):1541-50. Anticancer Res. 2008. PMID: 18630509 Free article. Review.

6

Apoptotic pathways in pancreatic ductal adenocarcinoma.

Hamacher R, Schmid RM, Saur D, Schneider G. Hamacher R, et al. Among authors: saur d. Mol Cancer. 2008 Jul 24;7:64. doi: 10.1186/1476-4598-7-64. Mol Cancer. 2008. PMID: 18652674 Free PMC article. Review.

7

Targeting histone deacetylases in pancreatic ductal adenocarcinoma.

Schneider G, Krämer OH, Fritsche P, Schüler S, Schmid RM, Saur D. Schneider G, et al. Among authors: saur d. J Cell Mol Med. 2010 Jun;14(6A):1255-63. doi: 10.1111/j.1582-4934.2009.00974.x. Epub 2009 Nov 19. J Cell Mol Med. 2010. PMID: 19929947 Free PMC article. Review.

8

HDAC2 attenuates TRAIL-induced apoptosis of pancreatic cancer cells.

Schüler S, Fritsche P, Diersch S, Arlt A, Schmid RM, Saur D, Schneider G. Schüler S, et al. Among authors: saur d. Mol Cancer. 2010 Apr 16;9:80. doi: 10.1186/1476-4598-9-80. Mol Cancer. 2010. PMID: 20398369 Free PMC article.

9

Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.

Schneider G, Krämer OH, Schmid RM, Saur D. Schneider G, et al. Among authors: saur d. J Gastrointest Cancer. 2011 Jun;42(2):85-92. doi: 10.1007/s12029-011-9257-1. J Gastrointest Cancer. 2011. PMID: 21271301 Review.

10

Disclosure of erlotinib as a multikinase inhibitor in pancreatic ductal adenocarcinoma.

Conradt L, Godl K, Schaab C, Tebbe A, Eser S, Diersch S, Michalski CW, Kleeff J, Schnieke A, Schmid RM, Saur D, Schneider G. Conradt L, et al. Among authors: saur d. Neoplasia. 2011 Nov;13(11):1026-34. doi: 10.1593/neo.111016. Neoplasia. 2011. PMID: 22131878 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters